M&A Strategy

Goals of M&A

As our strategy for the future, we are actively engaged in establishing our own unique businesses and in making corporate acquisitions to increase sales of our businesses other than human resources services.

Basic M&A Policies

Acquiring 100% of a company's stock is our basic principle. On the premise that we can leverage our knowledge and experience in research in the physical sciences and our knowhow in the business fields that define our company - namely chemistry, bioengineering-related fields, drug manufacture-related fields, certain areas of engineering, and CRO-related fields - in we will make a direct approach via WDB Business Succession Partners to the companies that we feel will contribute to the our group synergy. Following merger and acquisition, we will incorporate a company as a subsidiary into our growth strategy, with our sights set on unlimited growth and development.

M&A Track Record

Month/Year Business Field Description
1 September 2003 Human resource service Purchased the rights to operate branches of Human West Co., Ltd. in Okayama, Hiroshima, Takamatsu and Tokushima.
2 March 2005 Human resource service Genomic Brain is made a wholly-owned subsidiary through share acquisition.
3 July 2008 Human resource service Acquired the business rights to Santoku Life Co., Ltd.
4 October 2008 R&D/Manufacturing (Chemical) Kilo Technology Research Laboratory Co., Ltd. (WDB Functional Chemistry Co., Ltd.) is made a wholly-owned subsidiary through share acquisition.※1
5 January 2009 R&D/Manufacturing (Bioengineering) Acquired the fixed assets of Tasaki Co., Ltd. and established an environmental/biology research facility.※2
6 April 2011 CRO Used stock acquisition to make ICO Co., Ltd. (Now WDB coco Co., Ltd.) a wholly-owned subsidiary.
7 March 2013 CRO Used a stock acquisition to make Densuke Systems Ltd. (Now Densuke Systems Co., Ltd.) a wholly-owned subsidiary.
8 April 2014 R&D/Manufacturing (Engineering) Kaken Geneqs Co., Ltd. made a wholly-owned subsidiary through share acquisition.
9 March 2017 CRO Oy Medfiles Ltd. made a wholly-owned subsidiary through share acquisition.
10 June 2017 CRO Cobridge Co., Ltd. made a wholly-owned subsidiary through share acquisition.
11 August 2018 CRO A subsidiary WDB Medical Data, Inc. used stock acquisition to make DZS Software Solutions, Inc. a wholly-owned subsidiary.

※1.Dissolution in December 2018  ※2.Transfered all shares in December 2018